SG43311A1 - Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments - Google Patents

Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments

Info

Publication number
SG43311A1
SG43311A1 SG1996008047A SG1996008047A SG43311A1 SG 43311 A1 SG43311 A1 SG 43311A1 SG 1996008047 A SG1996008047 A SG 1996008047A SG 1996008047 A SG1996008047 A SG 1996008047A SG 43311 A1 SG43311 A1 SG 43311A1
Authority
SG
Singapore
Prior art keywords
sub
sup
alkyl
cycloalkyl
phenyl
Prior art date
Application number
SG1996008047A
Other languages
English (en)
Inventor
David Cedric Humber
George Blanch Ewan
Ian Harold Coates
James Angus Bell
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40347948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43311(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SG43311A1 publication Critical patent/SG43311A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG1996008047A 1985-06-25 1986-06-24 Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments SG43311A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858516083A GB8516083D0 (en) 1985-06-25 1985-06-25 Heterocyclic compounds
GB868628474A GB8628474D0 (en) 1985-06-25 1986-11-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SG43311A1 true SG43311A1 (en) 1997-10-17

Family

ID=40347948

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008047A SG43311A1 (en) 1985-06-25 1986-06-24 Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments

Country Status (22)

Country Link
US (2) US4753789A (fr)
EP (2) EP0226266B1 (fr)
JP (2) JPS6253920A (fr)
AT (2) ATE134510T1 (fr)
AU (2) AU609028B2 (fr)
BE (1) BE1002249A4 (fr)
CA (1) CA1296637C (fr)
CH (1) CH672068A5 (fr)
CY (1) CY2000A (fr)
DE (2) DE3650488T2 (fr)
DK (1) DK624687A (fr)
FR (1) FR2613934B1 (fr)
GB (3) GB8516083D0 (fr)
HK (1) HK82597A (fr)
IE (1) IE60908B1 (fr)
IL (1) IL84638A (fr)
IT (1) IT1211937B (fr)
NL (1) NL8702853A (fr)
NZ (1) NZ222743A (fr)
SE (1) SE8704747L (fr)
SG (1) SG43311A1 (fr)
ZA (1) ZA878927B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
IE60991B1 (en) * 1986-12-17 1994-09-07 Glaxo Group Ltd Use of ketone derivatives in the treatment of cognitive disorders
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
JPH0754759B2 (ja) * 1987-04-27 1995-06-07 日本電信電話株式会社 プラズマ処理方法および装置並びにプラズマ処理装置用モード変換器
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
US4971651A (en) * 1990-02-05 1990-11-20 Hitachi, Ltd. Microwave plasma processing method and apparatus
EP0591395A1 (fr) * 1991-06-26 1994-04-13 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur s(-)
WO1993000074A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur r(+)
EP0916346A3 (fr) * 1991-09-20 2000-12-06 Glaxo Group Limited Recepteurs antagonistes NK-1 et recepteurs antagonistes 5HT3 pour le traitement des vomissements
CA2157671A1 (fr) * 1993-03-08 1994-09-15 Kiyotaka Katsuta Medicament pour le traitment ou la prevention des maladies cerebrovasculaires
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
JP2002538102A (ja) * 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
KR100434390B1 (ko) * 2001-04-20 2004-06-04 안국약품 주식회사 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온을 유효성분으로 하는 비강분무용조성물
WO2004045615A1 (fr) * 2002-11-15 2004-06-03 Helsinn Healthcare Sa Methode pour traiter les vomissements
BRPI0406748A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Método de tratamento de náusea, vÈmito e ânsia de vÈmito ou qualquer combinação destes em um paciente que necessite do mesmo e composição farmacêutica
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
WO2005108392A2 (fr) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Procede de preparation de chlorhydrate dihydrate d'ondansetron ayant une granulometrie definie
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
WO2006105117A2 (fr) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Procede destine a traiter des troubles et des conditions au moyen d'inhibiteurs et d'antagonistes a peripherie restreinte
AU2007308378B2 (en) * 2006-10-24 2013-02-21 Helsinn Healthcare S.A. Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
JP2010050046A (ja) 2008-08-25 2010-03-04 Hitachi High-Technologies Corp プラズマ処理装置
CA2784587A1 (fr) 2009-12-28 2011-07-28 Monosol Rx, Llc Formes pharmaceutiques se presentant sous la forme de films administrables par voie orale contenant de l'ondansetron
MX342993B (es) 2013-04-25 2016-10-13 Inst Mexicano Del Petróleo Proceso de obtencion de copolimeros aleatorios derivados del acido itaconico y/o sus isomeros y alquenil sulfonatos de sodio y uso del producto obtenido.
WO2018129434A1 (fr) 2017-01-09 2018-07-12 Gt Biopharma, Inc. Utilisation et composition pour traiter la myasthénie grave et d'autres syndromes myasthéniques

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040489A1 (fr) * 1980-05-17 1981-11-25 FISONS plc Mélanges, sels, emballages et compositions pharmaceutiques contenant l'acide 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyrane-2-carboxylique ou un de ses dérivés et une antihistamine antagoniste des récepteurs H2
BE894285A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3502508A1 (de) * 1984-01-25 1985-08-14 Glaxo Group Ltd., London Heterocyclische verbindungen
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
IL84638A (en) 1992-05-25
EP0226266A3 (en) 1990-01-24
BE1002249A4 (fr) 1990-11-06
AU8191487A (en) 1988-06-02
AT395374B (de) 1992-12-10
EP0226266A2 (fr) 1987-06-24
EP0226266B1 (fr) 1996-02-28
US4753789A (en) 1988-06-28
DK624687A (da) 1988-05-29
EP0431443A3 (en) 1991-09-18
DK624687D0 (da) 1987-11-27
SE8704747L (sv) 1988-05-29
FR2613934A1 (fr) 1988-10-21
DE3740351A1 (de) 1988-06-09
CH672068A5 (fr) 1989-10-31
CY2000A (en) 1997-12-05
IT1211937B (it) 1989-11-08
AU616386B2 (en) 1991-10-31
IE873230L (en) 1988-05-28
NZ222743A (en) 1991-09-25
AU609028B2 (en) 1991-04-26
US4929632A (en) 1990-05-29
JPH0324447B2 (fr) 1991-04-03
NL8702853A (nl) 1988-06-16
GB8516083D0 (en) 1985-07-31
IE60908B1 (en) 1994-08-24
GB2200046B (en) 1990-09-26
GB2200046A (en) 1988-07-27
GB8628474D0 (en) 1987-01-07
HK82597A (en) 1997-06-27
ATA312587A (de) 1992-05-15
GB8727836D0 (en) 1987-12-31
ATE134510T1 (de) 1996-03-15
FR2613934B1 (fr) 1993-07-09
EP0431443A2 (fr) 1991-06-12
IT8748643A0 (it) 1987-11-27
DE3650488T2 (de) 1996-09-05
ZA878927B (en) 1988-10-26
CA1296637C (fr) 1992-03-03
JPS63198623A (ja) 1988-08-17
DE3650488D1 (de) 1996-04-04
AU6703786A (en) 1988-06-30
JPS6253920A (ja) 1987-03-09
SE8704747D0 (sv) 1987-11-27

Similar Documents

Publication Publication Date Title
HK82597A (en) Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
EP0389282A3 (fr) Dérivés de xanthine, procédé pour leur préparation et leur utilisation médicinale
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
EP0210753A3 (fr) Médicament antitumoral
NZ227082A (en) N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic acid; process for their preparation; and pharmaceutical compositions containing them
IL70797A (en) Triazole derivatives,their preparation and pharmaceutical and agricultural compositions containing them
IL70253A0 (en) Nitrosourea derivatives,their preparation and pharmaceutical compositions containing them
MY103293A (en) N-imidazolyl derivatives of bicyclic compounds useful in medicine
ES2001893A6 (es) Procedimiento para la obtencion de derivados de metilendioxifenantreno
GB2152508A (en) Pyrimidine derivatives
EP0204172A3 (en) Phenylpyrazine derivatives, processes for preparing them, pharmaceutical composition and use
EP0240986A3 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use
AU1675692A (en) Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
ES8407057A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES487971A1 (es) Procedimiento para la preparacion de nuevos derivados de p-cloroacetofenona oxima con actividad analgesica
EP0133578A3 (en) 3-aryl-3-pyrroline derivatives, process for their preparation, and medicaments containing them for the treatment of heart and vascular diseases